Peptide Purity Testing: HPLC and Mass Spectrometry Explained

Why Purity Matters in Peptide Research

The quality of results in peptide research is directly dependent on the quality of the peptides used. Impurities—whether from incomplete synthesis, side reactions, or degradation—can confound experimental results, introduce unexpected biological activities, or reduce the effective concentration of the target peptide. This is why rigorous purity testing is non-negotiable for serious research.

Two complementary analytical techniques form the gold standard for peptide quality verification: High-Performance Liquid Chromatography (HPLC) for purity assessment and Mass Spectrometry (MS) for identity confirmation. Together, they answer the two fundamental questions: “How pure is it?” and “Is it the right molecule?”

High-Performance Liquid Chromatography (HPLC)

How HPLC Works

HPLC separates the components of a mixture based on their chemical properties. In peptide analysis, reverse-phase HPLC (RP-HPLC) is the standard method:

Sample preparation: A small quantity of the peptide is dissolved in a suitable solvent (typically water/acetonitrile with TFA)
Column separation: The sample is injected into a column packed with C18-modified silica particles. Different molecules travel through the column at different rates based on their hydrophobicity
Detection: A UV detector (typically at 214 nm or 220 nm, which detects the peptide bond) records the signal as molecules elute from the column
Chromatogram output: The result is a graph showing peaks at different retention times. Each peak represents a different molecular species

Reading a Chromatogram

The HPLC chromatogram is the primary document on a Certificate of Analysis. Key elements include:

Main peak: The largest peak corresponds to the target peptide. Its area relative to all peaks determines the purity percentage
Retention time: When the target peptide elutes from the column. This should be consistent with the known retention time for that peptide under the same conditions
Minor peaks: Smaller peaks represent impurities—deletion sequences, truncated peptides, oxidized forms, or other synthesis byproducts
Baseline: A flat, stable baseline indicates good instrument performance and clean sample

Purity Calculation

Purity is calculated by dividing the area of the main peak by the total area of all peaks:

Purity (%) = (Area of main peak / Total area of all peaks) × 100

Purity Level	Typical Application
≥99%	High-grade research, quantitative studies
≥98%	Standard research grade, most applications
95-98%	Screening studies, preliminary research
90-95%	Limited applications, not recommended for quantitative work
<90%	Crude material, requires further purification

Mass Spectrometry (MS)

How Mass Spectrometry Works

While HPLC tells you how pure a sample is, mass spectrometry confirms that the main component is actually the correct peptide. The technique measures the mass-to-charge ratio (m/z) of ionized molecules:

Ionization: The peptide sample is converted to gas-phase ions, typically using electrospray ionization (ESI) or matrix-assisted laser desorption/ionization (MALDI)
Mass analysis: Ions are separated by their mass-to-charge ratio using electromagnetic fields
Detection: A detector records the abundance of ions at each m/z value
Mass spectrum: The output shows peaks corresponding to different charge states of the molecule

Interpreting Mass Spec Results

For peptide identity confirmation:

Expected molecular weight: The measured mass should match the theoretical molecular weight calculated from the amino acid sequence (typically within ±0.1% or ±1 Da)
Charge states: Peptides often appear as multiply charged ions ([M+2H]²⁺, [M+3H]³⁺, etc.). Software deconvolutes these to determine the actual molecular weight
Adducts: Sodium or potassium adducts may appear as additional peaks at +22 or +38 Da respectively

Peptide	Expected MW (Da)
BPC-157	1,419.53
TB-500	4,963.44
GHK-Cu	403.93

Understanding Certificates of Analysis (COAs)

What a Complete COA Should Include

Product name and catalog/lot number
Amino acid sequence of the peptide
HPLC purity percentage with chromatogram
Mass spectrometry result with expected and observed MW
Physical appearance description
Solubility information
Net peptide content
Storage recommendations
Date of analysis
Analyst signature or authorization

Quality Red Flags

When evaluating peptide quality from any supplier, watch for these warning signs:

No COA provided: Reputable suppliers always provide a COA. If one isn’t available, question the product’s quality
Missing mass spec data: HPLC purity alone doesn’t confirm identity. Without mass spec, you can’t be sure you have the right peptide
Unusually low prices: Peptide synthesis has real costs. Significantly below-market pricing often indicates lower purity, smaller quantities, or questionable sourcing
Vague purity claims: Statements like “high purity” without a specific percentage and supporting HPLC data are meaningless
No lot number: Traceability is essential for quality control. Each batch should have a unique lot number
Chromatogram shows broad or multiple peaks: This indicates impurities or degradation products
Mass spec deviation >0.5%: Large deviations from expected molecular weight suggest a different compound or significant modifications

CertaPeptides Quality Commitment

At CertaPeptides, every peptide we supply undergoes both HPLC purity testing and mass spectrometry identity verification. Our standard is ≥99% purity for all research peptides, with full COAs available for every lot. We believe that transparency in quality documentation is not optional—it is the foundation of reliable research.

Research Use Disclaimer

All products and information provided by CertaPeptides are intended exclusively for in vitro and in vivo research purposes. They are not intended for human consumption, therapeutic use, or diagnostic purposes. Researchers are responsible for ensuring compliance with all applicable institutional, local, and national regulations.

Advanced Testing: Endotoxin and Bioburden Analysis (Updated 2026)

Beyond HPLC and mass spectrometry, comprehensive peptide quality assurance includes testing for microbial contamination (bioburden) and bacterial endotoxins. These tests are critical for any research protocol involving parenteral (injected) administration. This section details these complementary testing methodologies.

Endotoxin Testing: LAL (Limulus Amebocyte Lysate) Assay

What is Endotoxin?

Endotoxins are lipopolysaccharides (LPS) found in the outer membrane of gram-negative bacteria. Even after bacterial cells are dead and filtered away, endotoxins remain in solution and can trigger powerful immune responses in mammalian tissue.

When endotoxins contact blood, tissue, or parenteral administration sites, they activate toll-like receptors (TLR4) on immune cells, triggering cytokine release and inflammatory cascades. Endotoxemia (high endotoxin levels) can cause fever, hypotension, shock, and tissue damage.

The LAL Test

The Limulus Amebocyte Lysate (LAL) test is the gold-standard endotoxin assay:

Source: LAL is an extract from hemocytes (blood cells) of Limulus polyphemus (horseshoe crab), which has evolved a sensitive endotoxin-detection system.
Mechanism: Endotoxin activates Factor C (a protease cascade) in the LAL reagent, leading to clot formation. The time-to-clot is inversely proportional to endotoxin concentration.
Sensitivity: Detects endotoxin at concentrations as low as 0.005-0.1 endotoxin units per mL (EU/mL), depending on test methodology.
Quantification: Modern kinetic chromogenic LAL assays provide quantitative results in EU/mL or ng/mL LPS equivalent.

LAL Results and Interpretation

Acceptable Threshold: FDA guidance for parenteral drugs is typically <175 EU/V (where V is injection volume in mL). For research peptides, <10 EU/mL is standard.
Typical CertaPeptides Results: All peptides undergo LAL testing; results typically show <0.1-1.0 EU/mL (far below regulatory limits).
Positive Result: >10 EU/mL indicates gram-negative bacterial contamination during manufacturing, storage, or reconstitution. Peptide batch should be considered unsuitable.
Failed Reconstitution: If reconstituted solution shows elevated endotoxin despite low starting material, contamination occurred during reconstitution—discard and re-reconstitute with fresh, sterile bacteriostatic water.

Bioburden Testing: Viable Cell Count

What is Bioburden?

Bioburden is the total number of viable (living) microorganisms present in a sample. While endotoxin testing detects bacterial components (dead or alive), bioburden testing counts living organisms that could proliferate if given appropriate conditions.

Testing Methodologies

Traditional Culture Methods (Gold Standard):

Plate Count Method: Dilute sample and culture on growth media (aerobic and anaerobic). Colonies are counted after 24-72 hours incubation at 30-37°C.
Advantage: Identifies specific organisms (bacteria vs. fungi) and allows sensitivity testing.
Disadvantage: Slow (24-72 hours). Some organisms are non-culturable in standard media.
Typical Results: Pharmaceutical-grade peptides: <10 CFU/mL (colony-forming units per mL). <1 CFU/mL is typical.

Rapid Methods (ATP Bioluminescence):

ATP Assay: Living cells contain adenosine triphosphate (ATP). ATP is combined with luciferase enzyme; light production is proportional to microbial load.
Advantage: Results in 15-30 minutes; detects viable cells regardless of culture ability.
Disadvantage: Cannot identify organism types; may have false positives from food debris or other ATP sources.
Typical Results: <10-100 RLU (relative light units) for acceptable pharmaceutical peptides.

qPCR-Based Methods (Emerging):

Quantitative Polymerase Chain Reaction: Detects and quantifies bacterial DNA/RNA. Very rapid (<2 hours) and sensitive.
Advantage: Fast, quantitative, identifies organisms to species level.
Disadvantage: More expensive; cannot distinguish viable from dead organisms (detects all DNA).
Use Case: Quality control and process validation rather than routine testing.

CertaPeptides Quality Assurance: Full Testing Profile

All CertaPeptides products undergo comprehensive quality testing including:

HPLC Analysis: Purity (>95%)
Mass Spectrometry: Molecular weight confirmation
Potency Bioassay: Biological activity verification (where applicable)
LAL Endotoxin Test: <1.0 EU/mL (far below regulatory limits)
Viable Bioburden: <1 CFU/mL (pharmaceutical grade)
Sterility Test: 14-day culture in fluid media; negative (no growth)
Bacterial Contamination Screening: Gram stain and culture identification of any positive cultures

Full Certificates of Analysis documenting all results are provided with every order. See our How to Read a COA guide for interpretation.

What Testing Means for Your Research

Endotoxin Implications

Local Administration: Low endotoxin (<10 EU/mL) is acceptable for localized injection (subcutaneous, intralesional). Local inflammation is minimized.
Systemic Administration: IV or intravenous routes require <5 EU per dose (extremely stringent). Most research uses subcutaneous/intramuscular routes which are more forgiving.
Inflammatory Research: If studying anti-inflammatory effects, endotoxin-free peptides are critical. Any baseline inflammatory trigger (from endotoxin) will confound results.
Safety Margin: CertaPeptides’ <1.0 EU/mL provides enormous safety margin. Even if peptide solution becomes contaminated post-receipt, 100-1000x multiplication would be needed to reach problematic levels.

Bioburden Implications

Long-Term Storage: Lyophilized peptides with minimal bioburden (<1 CFU/mL) remain stable long-term (years) because organisms cannot proliferate in dry, frozen state.
Reconstituted Solutions: Even pharmaceutical-grade peptides (starting <1 CFU/mL) will eventually develop bioburden if stored too long or contaminated during reconstitution. This is why we recommend 3-4 week maximum storage of reconstituted solutions.
Aseptic Technique Critical: A sterile starting material (no organisms) combined with non-sterile reconstitution technique will rapidly accumulate organisms. The solution is only as clean as your handling.
Verification: If concerned about microbial contamination, culture a small sample of your reconstituted solution at 37°C for 24-48 hours. Any turbidity indicates growth; the solution should be discarded.

Contamination Troubleshooting: When Something Goes Wrong

Received Peptide Shows High Bioburden

Likelihood: Extremely rare with CertaPeptides (all batches tested). If this occurs, contact support with batch number and Certificate of Analysis.
Resolution: Replacement batch provided immediately, or full refund. Manufacturing issue investigation is conducted.

Reconstituted Solution Shows Turbidity Within Days

Likely Cause: Contamination during reconstitution (non-sterile needle, glove contact, open reconstitution environment).
Prevention: Always use sterile technique—sterile gloves, sterile needles (new for each use), alcohol wipe the vial septum, avoid talking over the open vial.
Solution: Discard contaminated solution. Re-reconstitute with fresh bacteriostatic water using strict aseptic technique.

Solution Becomes Discolored After 2-3 Weeks

Likely Cause: Microbial growth (likely fungal), oxidation, or peptide degradation.
Indicator: Yellow, pink, or brown discoloration indicates chemical changes or organism pigment production.
Solution: Discard. Color change indicates the solution is no longer suitable for research.

Conclusion: Comprehensive Quality Assurance

HPLC and mass spectrometry confirm peptide purity and identity; endotoxin (LAL) and bioburden testing confirm microbiological safety. Together, these assays provide complete quality assurance that your research peptides are pure, potent, and safe for parenteral administration. CertaPeptides’ comprehensive testing ensures research-grade quality for every batch. See our Quality Assurance page for detailed testing methodology and typical results.